The latest price target for Astera Labs (NASDAQ:ALAB) was reported by Morgan Stanley on December 20, 2024. The analyst firm set a price target for $142.00 expecting ALAB to rise to within 12 months (a possible 2.64% upside). 34 analyst firms have reported ratings in the last year.

The latest analyst rating for Astera Labs (NASDAQ:ALAB) was provided by Morgan Stanley, and Astera Labs maintained their overweight rating.

The last upgrade for Astera Labs Inc happened on September 4, 2024 when Morgan Stanley raised their price target to $55. Morgan Stanley previously had an equal-weight for Astera Labs Inc.

There is no last downgrade for Astera Labs.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Astera Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Astera Labs was filed on December 20, 2024 so you should expect the next rating to be made available sometime around December 20, 2025.

While ratings are subjective and will change, the latest Astera Labs (ALAB) rating was a maintained with a price target of $94.00 to $142.00. The current price Astera Labs (ALAB) is trading at is $138.35, which is within the analyst’s predicted range.